Ignite Creation Date:
2024-05-06 @ 6:02 PM
Last Modification Date:
2024-10-26 @ 2:40 PM
Study NCT ID:
NCT05523440
Status:
RECRUITING
Last Update Posted:
2024-02-15
First Post:
2022-08-29
Brief Title:
Bevacizumab andor Niraparib in Patients With Recurrent Endometrial andor Ovarian Cancer With ARID1A Mutation
Sponsor:
University of Oklahoma
Organization:
University of Oklahoma